Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor

DA Vallera, A Panoskaltsis-Mortari, C Jost, S Ramakrishnan, CR Eide, RJ Kreitman, PJ Nicholls, C Pennell, BR Blazar

Blood (1996) 88 (6): 2342–2353.

https://doi.org/10.1182/blood.V88.6.2342.bloodjournal8862342

Published: 1996

Journal Articles

Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells

CH Chan, BR Blazar, L Greenfield, RJ Kreitman, DA Vallera

Blood (1996) 88 (4): 1445–1456.

https://doi.org/10.1182/blood.V88.4.1445.bloodjournal8841445

Published: 1996

Journal Articles

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, JA Bluestone, DA Vallera

Blood (1996) 87 (10): 4463–4472.

https://doi.org/10.1182/blood.V87.10.4463.bloodjournal87104463

Published: 1996

Journal Articles

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, S Sehgal, DA Vallera

Blood (1996) 87 (9): 4001–4009.

https://doi.org/10.1182/blood.V87.9.4001.bloodjournal8794001

Published: 1996

Journal Articles

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

JW Fay, JR Wingard, JH Antin, RH Collins, LA Pineiro, BR Blazar, R Saral, BE Bierer, D Przepiorka, WE Fitzsimmons, RM Maher, DJ Weisdorf

Blood (1996) 87 (8): 3514–3519.

https://doi.org/10.1182/blood.V87.8.3514.bloodjournal8783514

Published: 1996

Journal Articles

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, TA Barrett, JA Bluestone, DA Vallera

Blood (1996) 87 (2): 827–837.

https://doi.org/10.1182/blood.V87.2.827.bloodjournal872827

Published: 1996

Journal Articles

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

DA Vallera, PA Taylor, A Panoskaltsis-Mortari, BR Blazar

Blood (1995) 86 (11): 4367–4375.

https://doi.org/10.1182/blood.V86.11.4367.bloodjournal86114367

Published: 1995

Journal Articles

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities

BR Blazar, PA Taylor, DA Vallera

Blood (1995) 86 (11): 4353–4366.

https://doi.org/10.1182/blood.V86.11.4353.bloodjournal86114353

Published: 1995

Journal Articles

A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells

CH Chan, BR Blazar, CR Eide, RJ Kreitman, DA Vallera

Blood (1995) 86 (7): 2732–2740.

https://doi.org/10.1182/blood.V86.7.2732.2732

Published: 1995

Journal Articles

Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome

SM Davies, XO Shu, BR Blazar, AH Filipovich, JH Kersey, W Krivit, J McCullough, WJ Miller, NK Ramsay, M Segall

Blood (1995) 86 (4): 1636–1642.

https://doi.org/10.1182/blood.V86.4.1636.bloodjournal8641636

Published: 1995

Journal Articles

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages

R Bhatia, PB McGlave, GW Dewald, BR Blazar, CM Verfaillie

Blood (1995) 85 (12): 3636–3645.

https://doi.org/10.1182/blood.V85.12.3636.bloodjournal85123636

Published: 1995

Journal Articles

Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia

MW Boyer, PJ Orchard, KB Gorden, PM Anderson, RS Mclvor, BR Blazar

Blood (1995) 85 (9): 2498–2506.

https://doi.org/10.1182/blood.V85.9.2498.bloodjournal8592498

Published: 1995

Journal Articles

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, GS Gray, DA Vallera

Blood (1995) 85 (9): 2607–2618.

https://doi.org/10.1182/blood.V85.9.2607.bloodjournal8592607

Published: 1995

Journal Articles

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts

BR Blazar, PA Taylor, S Smith, DA Vallera

Blood (1995) 85 (3): 842–851.

https://doi.org/10.1182/blood.V85.3.842.bloodjournal853842

Published: 1995

Journal Articles

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients

BR Blazar, PA Taylor, DA Vallera

Blood (1995) 85 (3): 833–841.

https://doi.org/10.1182/blood.V85.3.833.bloodjournal853833

Published: 1995

Journal Articles

Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial

D Weisdorf, E Katsanis, C Verfaillie, NK Ramsay, R Haake, L Garrison, BR Blazar

Blood (1994) 84 (6): 2044–2049.

https://doi.org/10.1182/blood.V84.6.2044.2044

Published: 1994

Journal Articles

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

BR Blazar, PA Taylor, PS Linsley, DA Vallera

Blood (1994) 83 (12): 3815–3825.

https://doi.org/10.1182/blood.V83.12.3815.3815

Published: 1994

Journal Articles

Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow [published erratum appears in Blood 1994 Jun 1;83(11):3424-5]

BR Blazar, PA Taylor, SN Sehgal, DA Vallera

Blood (1994) 83 (2): 600–609.

https://doi.org/10.1182/blood.V83.2.600.600

Published: 1994

Journal Articles

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha [see comments]

BR Blazar, MB Widmer, PA Taylor, DA Vallera

Blood (1992) 80 (6): 1614–1622.

https://doi.org/10.1182/blood.V80.6.1614.1614

Published: 1992

Journal Articles

Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non- depleted syngeneic bone marrow transplants

BR Blazar, SL Aukerman, DA Vallera

Blood (1992) 79 (6): 1636–1642.

https://doi.org/10.1182/blood.V79.6.1636.1636

Published: 1992

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor

Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities

A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells

Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome

Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages

Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients

Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow [published erratum appears in Blood 1994 Jun 1;83(11):3424-5]

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha [see comments]

Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non- depleted syngeneic bone marrow transplants

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only